THE EFFECT OF PROMOTION FOR SELF-CARE BEHAVIOR PROGRAM ON HAND AND FOOT SYNDROME USING APPLICATION IN COLORECTAL CANCER PATIENTS RECEIVING CAPECITABINE

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

TCTR

Registry ID

TCTR20260710011

Enrollment

Registered

2026-07-10

Start date

2024-03-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer patients receiving capecitabine and hand-foot syndrome application-based self-care promotion program, hand-foot syndrome (HFS), medication adherence, self-care behaviors, quality of life (QoL) and colorectal cancer patients receiving capecitabine

Interventions

Application-Based Self-Care Promotion Program Phases: Phase 1: Assessment and Goal Setting: Establish rapport, identify barriers to capecitabine therapy and individual needs, and develop collaborative

Experimental Other,No Intervention Other

THE EFFECT OF PROMOTION FOR SELF-CARE BEHAVIOR PROGRAM,Standard of care

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1 Male or female patients aged 18 years and older. For participants over 60, normal cognitive function must be demonstrated by a Six-item Cognitive Impairment Test (6CIT) score of 0 7 (indicating no cognitive impairment) 2 Eastern Cooperative Oncology Group (ECOG) performance status score of 0 2 3 Diagnosed with colorectal cancer and scheduled to receive Capecitabine chemotherapy for the first time 4 Fully conscious and able to communicate effectively in Thai 5 Willingness to provide informed consent and participate in the study

Exclusion criteria

Exclusion criteria: 1. Patients receiving concurrent treatments during chemotherapy, such as radiotherapy. 2. Inability to use or access a smartphone with the Android operating system.

Design outcomes

Primary

Measure	Time frame
Severity of hand-foot syndrome (HFS) 3 Months National cancer institute common terminology criteria for adverse events - version 5.0 (NCI-CTCAE v5.0)	—

Secondary

Measure	Time frame
Medication adherence (MA) 3 Months Morisky Medication Adherence Scale : MMAS-8),Self-care behaviors 3 Months The Self-Care Behavior Questionnaire for colorectal cancer patients receiving capecitabine is a 12-item, researcher-developed instrument synthesized from an extensive literature review.,Quality of life (QoL) 3 Months Hand-Foot Syndrome-14	—

Countries

Thailand

Contacts

Public ContactApatnipa Boonlee

Faculty of Medicine Ramathibodi Hospital

apatnipa@nmu.ac.th0817333648

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026